"With rare exceptions, all 40-year-olds are alike. ... When you have seen one 85...
AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechno...
AbbVie has signed an agreement with Tentarix Biotherapeutics to discover and dev...
The EMA has granted an accelerated review of CHIKV VLP as Bavarian Nordic attemp...
Moderna has reported a net loss of $4.7bn for the full year 2023 as against a ne...
The UK NICE has recommended Pfizer's Ritlecitinib as a new treatment option for ...
The FDA Office of Generic Drugs reported a rise in generic drug approvals, as se...
The positive opinion is based on findings from the Phase III COMMANDS trial whic...
Sanofi and Regeneron’s Dupixent has received priority review by the US FDA, with...
Following major successes in the RSV landscape over the last few years, experts ...
The widespread use of new weight loss drugs in the U.S. could boost gross domest...
In an interview, Alnylam’s CEO defended changes to its all-important cardiovascu...
It was a controversial choice for Annovis Bio to change the endpoint of a Phase ...
Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire...
People are choosing home birth for vaginal delivery after cesarian and other hig...
STAT+ subscribers tried to stump Pharmalot, aka Ed Silverman. Here’s what they c...
